# PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects

> **NCT03586908** · PHASE1 · COMPLETED · sponsor: **pH Pharma** · enrollment: 24 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** PHP-201 0.5% ophthalmic solution (topical eye drop)

## Key facts

- **NCT ID:** NCT03586908
- **Lead sponsor:** pH Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-02-04
- **Primary completion:** 2018-02-27
- **Final completion:** 2018-03-09
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03586908

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03586908, "PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03586908. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*